Insider · CIK 0001814876
Terrance P. Coyne
cfoofficer
Files at RPRX (Royalty Pharma plc). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 16, 2025 | RPRX Royalty Pharma plc | AGrant or award Class E Ordinary Sharesderivativeindirect: See Footnote (1)(2) | +1,807,277 | $0.00 | $0 | 1,807,277 | May 20, 2025 |
| May 8, 2025 | RPRX Royalty Pharma plc | AGrant or award Class A Ordinary Sharesindirect: TPC RP EPA1 LLC | +48,646 | $0.00 | $0 | 48,646 | May 9, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.